Chemicals & Advanced Materials Global On demand · 24-48h

Global Astragalus Extract for Health Care Market Strategic Research Report

Global Astragalus Extract for Health Care Market Strategic R…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Astragalus Extract for Health Care Market
$16.652025
3.6%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Astragalus Polysaccharide, Astragaloside IV

By Application: Healthy Food, Pharmaceutical Industry, Feed Additives, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Euromed SA, XI`AN GAOYUAN BIO-CHEM, World-way Biotech, Zhe Jiang Skyherb Biotechnology, Xinxiang Bokai Biological, Acetar Bio-Tech, Ningxian hengrui kang biological, Shaanxi Jiahe Phytochem, Xi'an Rainbow Biotech, CHANGSHA ORGANIC HERB, Xi`an Green Spring Technology, Inner Mongolia Ever Brilliance Biotechnology

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 111 pages
Market size 2025
$16.65
Million USD
Forecast CAGR
3.6%
2025-2032
Forecast 2032
$21.3
Projected
Regiões
5
Asia Pacific · Latin America · MEA · Europe · North America

Visão geral

Scope of the Report

The global Astragalus Extract for Health Care market size is predicted to grow from US$ 16.65 million in 2025 to US$ 21.28 million in 2032; it is expected to grow at a CAGR of 3.6% from 2026 to 2032.

Astragalus membranaceus refers to the dry root of Astragalus membranaceus (Fisch.)Bge.or Astragalus mongolica(Fisch.)Bge.var.mongholicus(Bge.)Hsiao. Astragaloside IV is known as one of the major functional components in Astragalus membranaceus.

In 2022, the global sales of Astragalus extract reached 18.59 million US dollars, and it is projected to reach 23.81 million US dollars by 2029, with a compound annual growth rate (CAGR) of 3.31% during the period of 2023-2029. On a regional level, the Chinese market has witnessed rapid changes in recent years, with a market size of 10.82 million US dollars in 2022, accounting for approximately 58.23% of the global market share. It is expected to reach 13.28 million US dollars by 2029, with the global share anticipated to reach 55.79%. Astragalus extract, as an essential ingredient in health products, pharmaceutical industries, and feed additives, has a promising development outlook. The concept of "medicine and food sharing the same origin" is deeply rooted in the Chinese health industry, with the various nutritional components of Astragalus having the effects of regulating bodily functions, treating diseases, and enhancing physical fitness, thus establishing a broad market base. The advancement of modern nutrition science and preventive medicine has facilitated the widespread adoption of Astragalus extract globally, making it a crucial ingredient in pharmaceuticals, health products, and feed additives.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Astragalus Extract for Health Care market?

What factors are driving Astragalus Extract for Health Care market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Astragalus Extract for Health Care market opportunities vary by end market size?

How does Astragalus Extract for Health Care break out by Type, by Application?

This report presents a comprehensive overview of the global Astragalus Extract for Health Care market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Astragalus Polysaccharide
  • Astragaloside IV

Segment by Application

  • Healthy Food
  • Pharmaceutical Industry
  • Feed Additives
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Astragalus Extract for Health Care market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Healthy Food, Pharmaceutical Industry, Feed Additives evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Astragalus Extract for Health Care Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 3.6%
Regional growth momentum
Market share by segment
Key metrics
Base value
$16.65
2025
Forecast
$21.3
2032
CAGR
3.6%
2025–2032
Regiões
5
global
Key companies
Euromed SAXI`AN GAOYUAN BIO-CHEMWorld-way BiotechZhe Jiang Skyherb BiotechnologyXinxiang Bokai BiologicalAcetar Bio-TechNingxian hengrui kang biologicalShaanxi Jiahe Phytochem
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Astragalus PolysaccharideAstragaloside IV
By Application
Healthy FoodPharmaceutical IndustryFeed AdditivesOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Astragalus Polysaccharide
  • 3.1.3 Astragaloside IV
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Healthy Food
  • 4.1.3 Pharmaceutical Industry
  • 4.1.4 Feed Additives
  • 4.1.5 Other
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Euromed SA
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 XI`AN GAOYUAN BIO-CHEM
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 World-way Biotech
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Zhe Jiang Skyherb Biotechnology
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Xinxiang Bokai Biological
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Acetar Bio-Tech
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Ningxian hengrui kang biological
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Shaanxi Jiahe Phytochem
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Xi'an Rainbow Biotech
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 CHANGSHA ORGANIC HERB
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Xi`an Green Spring Technology
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Inner Mongolia Ever Brilliance Biotechnology
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Astragalus Extract for Health Care market size?
The global Astragalus Extract for Health Care market is estimated at US$ 16.65 million in 2025 (base year) and is projected to reach US$ 21.28 million by 2032.
What growth rate is expected for the Astragalus Extract for Health Care market through 2032?
The market is expected to grow at a CAGR of 3.6% from 2026 to 2032, expanding from US$ 16.65 million in 2025 to US$ 21.28 million in 2032, roughly 1.3 times its base-year value.
How is Astragalus Extract for Health Care defined?
Astragalus membranaceus refers to the dry root of Astragalus membranaceus (Fisch.)Bge.or Astragalus mongolica(Fisch.)Bge.var.mongholicus(Bge.)Hsiao. Astragaloside IV is known as one of the major functional components in Astragalus membranaceus.
What are the main segments of the Astragalus Extract for Health Care market by type?
By type, the market is segmented into Astragalus Polysaccharide and Astragaloside IV.
Which applications drive demand in the Astragalus Extract for Health Care market?
Key applications covered include Healthy Food, Pharmaceutical Industry, Feed Additives and Other.
Who are the key players in the Astragalus Extract for Health Care market?
Key players profiled include Euromed SA, XI`AN GAOYUAN BIO-CHEM, World-way Biotech, Zhe Jiang Skyherb Biotechnology, Xinxiang Bokai Biological, Acetar Bio-Tech, Ningxian hengrui kang biological and Shaanxi Jiahe Phytochem, among 12 companies covered in total.
Which regions and countries are covered for Astragalus Extract for Health Care?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Astragalus Extract for Health Care market?
What factors are driving Astragalus Extract for Health Care market growth, globally and by region?
Who should buy the Astragalus Extract for Health Care market report?
The report is intended for manufacturers and solution providers, distributors and end users in Healthy Food, Pharmaceutical Industry and Feed Additives, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Astragalus Extract for Health Care market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.